Deyee Robot (Shenzhen) Co.,Ltd announced the completion of a Series A++ financing round of several tens of millions of yuan. This round was invested by TianTu Beauty Leading (Huzhou) Equity Investment Partnership (Limited Partnership).
Series A++ Financing Completed
SHENZHEN, China — Deyee Robot (Shenzhen) Co.,Ltd (“Deyee Robot”) today announced the closing of a Series A++ financing round totaling several tens of millions of yuan. The round was led exclusively by TianTu Beauty Leading (Huzhou) Equity Investment Partnership (Limited Partnership) (the “TianTu Beauty Leading Fund”).
Proceeds from the round will be directed toward four key areas: further development of the Deep PT deep therapy large model and embodied intelligence robotics technology; acceleration of mass production across the company’s full portfolio of AI-powered health embodied intelligent robots; expansion of global market presence; and planning for the construction of an annual production base capable of manufacturing 10,000 units of AI health embodied intelligent robots. Collectively, these initiatives aim to consolidate Deyee Robot’s leading position in the AI-plus-health embodied intelligence robotics sector.
A Strategic Investor Across Wellness AI and Healthcare
The TianTu Beauty Leading Fund is a joint venture established by Hong Kong-listed TianTu Capital, in partnership with international beauty group L’Oréal (via Shanghai Meicifang Investment Co., Ltd.), along with multiple state-owned enterprises, industrial capital entities, and listed institutions including Huzhou Wuxing Jingkai Bogu Equity Investment Co., Ltd., Shanghai Fengpu Industrial Co., Ltd., Shenzhen TianTu Xingyi Investment Partnership (Limited Partnership), and Shenzhen TianTu Capital Management Center (Limited Partnership). The fund represents a specialized industrial investment platform in China that bridges beauty and wellness consumption, healthcare, and physical AI.
The investment in Deyee Robot marks a significant step in the TianTu Beauty Leading Fund’s strategic deployment across the converging domains of wellness, artificial intelligence, and healthcare. It underscores the fund’s conviction in the potential of embodied intelligence technology within beauty and wellness consumption, physical AI application scenarios, and the development of new quality productive forces.
TianTu Capital operates under a dual-drive model combining private equity fund management with proprietary direct investment, guided by research-driven, long-term value investing principles. The firm is committed to identifying and backing innovative enterprises poised to lead future industrial transformation.
Why TianTu Invested in Deyee Robot
Tang Zhimin, Partner at TianTu Capital, commented: “As AI technology continues to advance across both software and hardware applications, the market for medical service robotics holds tremendous promise. The therapy sector in particular is evolving from traditional manual treatment toward data-driven, standardized, and intelligent solutions. Deyee Robot has achieved a deep integration of vertical therapy large models with embodied intelligent hardware. Leveraging its proprietary algorithm systems, barriers to clinical evidence-based data, and mature medical-engineering translation capabilities, the company has built a unique and defensible composite technology moat in the industry.”
Li Kanglin, Partner at TianTu Investment and Head of the Beauty Navigation Fund, stated that the practical application of cutting-edge technologies and new materials in the beauty industry is the core investment focus of the Beauty Navigation Fund. By integrating AI algorithms with robotics technology, Deyee Robot has achieved large-scale implementation in beauty service scenarios and established a complete commercial ecosystem. Going forward, TianTu’s Beauty Navigation Fund will continue to identify high-quality innovative companies that possess technological barriers, practical application scenarios, and viable business models.
Full Stack Technology and Market Reach
As a globally leading AI plus wellness embodied intelligence robotics enterprise, Deyee Robot was founded in 2019 and is headquartered in Shenzhen. The company is recognized as a National High-Tech Enterprise and a “Specialized and Sophisticated” enterprise. Deyee Robot focuses on the research, development, production, sales, and service training of artificial intelligence algorithms, multimodal AI technologies, embodied robotic systems, and specialized medical technologies. The company is deeply embedded across the global health industry’s core verticals, spanning medical care, wellness, and senior care.
Committed to a full-stack proprietary technology and R&D philosophy, Deyee Robot has established a comprehensive core technology framework centered on the Deep PT large model. This ecosystem encompasses multimodal AI technologies, intelligent acupoint recognition, 3D vision algorithms, six-dimensional force control algorithms, deep learning training, and language interaction algorithms. The company has successfully developed highly competitive AI health robots that are widely deployed across diverse settings including beauty and wellness centers, spas, traditional Chinese medicine hospitals, community wellness centers, and senior care facilities.
Currently Deyee Robot’s products are available in over 200 cities across China and exported to more than 20 countries and regions worldwide. The company has established comprehensive partnerships with 9 listed corporations and serves over 5,000 partners globally.
Four Priorities After Series A++
With the infusion of Series A++ funding, building on the Series A+ round completed months earlier, Deyee Robot will accelerate the execution of four core strategic pillars:
1 Deep PT Large Model Advancement
Significantly scale the evidence-based database from the current 400,000-level to the million-level tier, redefining the next generation of AI health robots.
2 Clinical Ecosystem Deepening
Establish a hub for medical-engineering translation by creating a virtuous cycle of “clinical testing → laboratory R&D → market iteration and validation,” digitizing and productizing the expertise of leading medical professionals.
3 Super Factory Initiative
Launch the “Super Factory” initiative to lay a solid foundation for large-scale deliveries, maintain high product quality, achieve optimal delivery efficiency, and leverage cost advantages to effectively meet the surging market demand from global partners.
4 Global Commercialization and Cross Sector Collaboration
Drive worldwide adoption through deep coordination with global partners including L’Oréal, exploring cross-sector new business models such as “AI-powered tech-beauty” and “premium AI embodied intelligent health robots.” This effort aims to integrate 5,000 years of traditional Chinese medicinal wisdom with AI-plus-health embodied intelligence technologies and standardized service solutions.
Looking Ahead
Looking ahead, Deyee Robot remains steadfast in its core positioning of “AI + Robot Body + Scenarios + Data.” Leveraging the four strategic pillars as key drivers, the company will accelerate technological innovation in AI embodied intelligent robotics and its global industrial application. Deyee Robot is committed to empowering the digital and intelligent transformation of the global health industry.
